1. Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma. (1st March 2015) Authors: McBride, Ali; Klaus, Jeff O.; Stockerl-Goldstein, Keith Journal: American journal of health-system pharmacy Issue: Volume 72:Number 5(2015) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma. Issue 12 (15th October 2021) Authors: Liu, Lawrence; Fiala, Mark; Gao, Feng; King, Justin; Goldsmith, Scott; Wildes, Tanya M.; Stockerl-Goldstein, Keith; Vij, Ravi; Schroeder, Mark A. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 3043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment. (April 2022) Authors: Dimopoulos, Meletios A.; Mikhael, Joseph; Terpos, Evangelos; Leleu, Xavier; Moreau, Philippe; Bladé, Joan; Kim, Jin Seok; Stockerl-Goldstein, Keith; Richardson, Paul G. Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation. (October 2016) Authors: Ghobadi, Armin; Choi, Jaebok; Fiala, Mark A.; Fletcher, Theresa; Liu, Jingxia; Eissenberg, Linda G.; Abboud, Camille; Cashen, Amanda; Vij, Ravi; Schroeder, Mark A.; Pusic, Iskra; Stockerl-Goldstein, Keith; Jacoby, Meagan; Uy, Geoffrey; DiPersio, John; Westervelt, Peter Journal: Leukemia research Issue: Volume 49(2016:Oct.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation. Issue 1 (2nd January 2017) Authors: Fiala, Mark A.; Slade, Michael; Wang, Stephanie; Park, Soo; DiPersio, John; Stockerl-Goldstein, Keith Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome. Issue 11 (1st November 2016) Authors: Cherian, Mathew A.; Tibes, Raoul; Gao, Feng; Fletcher, Theresa; Fiala, Mark; Uy, Geoffrey L.; Westervelt, Peter; Jacoby, Meagan A.; Cashen, Amanda F.; Stockerl-Goldstein, Keith; DiPersio, John F.; Vij, Ravi Journal: Leukemia & lymphoma Issue: Volume 57:Issue 11(2016:Nov.) Page Start: 2535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation. (October 2016) Authors: Ghobadi, Armin; Choi, Jaebok; Fiala, Mark A.; Fletcher, Theresa; Liu, Jingxia; Eissenberg, Linda G.; Abboud, Camille; Cashen, Amanda; Vij, Ravi; Schroeder, Mark A.; Pusic, Iskra; Stockerl-Goldstein, Keith; Jacoby, Meagan; Uy, Geoffrey; DiPersio, John; Westervelt, Peter Journal: Leukemia research Issue: Volume 49(2016:Oct.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data. (September 2018) Authors: Ferraro, Francesca; Gao, Feng; Stockerl-Goldstein, Keith; Westervelt, Peter; DiPersio, John F.; Ghobadi, Armin Journal: Leukemia research Issue: Volume 72(2018) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes. Issue 6 (12th May 2021) Authors: Huselton, Eric; Rettig, Michael P.; Fletcher, Theresa; Ritchey, Julie; Gehrs, Leah; McFarland, Kyle; Christ, Stephanie; Eades, William C.; Trinkaus, Kathryn; Romee, Rizwan; Kulkarni, Shashikant; Ghobadi, Armin; Abboud, Camille; Cashen, Amanda F.; Stockerl-Goldstein, Keith; Uy, Geoffrey L.; Vij, R... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 6(2021) Page Start: 1441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗